Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity Correction

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European journal of drug metabolism and pharmacokinetics

• Publication date

  2016-04-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s13318-016-0336-3PMID 27101423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac

  2018cited by this paper
• Long-term culture of primary hepatocytes: new matrices and microfluidic devices

  2013cited by this paper
• Comparison of Cryopreserved HepaRG Cells with Cryopreserved Human Hepatocytes for Prediction of Clearance for 26 Drugs

  2012cited by this paper
• A Novel Relay Method for Determining Low-Clearance Values

  2012cited by this paper
• A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes.

  2012cited by this paper
• In-silico ADME models: a general assessment of their utility in drug discovery applications.

  2011cited by this paper
• Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View

  2010cited by this paper
• Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance.

  2008cited by this paper
• Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance

  2008cited by this paper
• Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds

  2008cited by this paper
• High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models.

  2008cited by this paper
• Hepatocellular Binding of Drugs: Correction for Unbound Fraction in Hepatocyte Incubations Using Microsomal Binding or Drug Lipophilicity Data

  2008cited by this paper
• Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

  2007cited by this paper
• Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species

  2007cited by this paper
• Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme

  2007cited by this paper
• Drug-drug interactions via mechanism-based cytochrome P450 inactivation: points to consider for risk assessment from in vitro data and clinical pharmacologic evaluation.

  2007cited by this paper
• Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability

  2006cited by this paper
• Prediction of in vitro intrinsic clearance from hepatocytes: comparison of suspensions and monolayer cultures.

  2005cited by this paper
• Measurement of excretion characteristics of theophylline and its major metabolites

  2004cited by this paper
• In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.

  2002cited by this paper
• Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

  1999cited by this paper
• Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics

  1996cited by this paper
• Collagen gel immobilization: a useful cell culture technique for long-term metabolic studies on human hepatocytes.

  1994cited by this paper
• Elimination kinetics and urinary excretion of disopyramide in human healthy volunteers.

  1988cited by this paper
• Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems

  1975cited by this paper

• Elucidating CYP2D6-driven metabolism and hepatotoxic bioactivation of metoprolol in plateable human and animal hepatocytes

  2025cites this paper
• First-in-Human Predictions of Hepatic Clearance for Drugs with the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics.

  2024cites this paper
• Clearance prediction with three novel plated human hepatocyte models compared to conventional suspension assays: Assessment with 50 compounds and multiple donors.

  2024cites this paper
• Considerations for Improving Metabolism Predictions for In Vitro to In Vivo Extrapolation

  2022cites this paper
• Variability in Human In Vitro Enzyme Kinetics.

  2021cites this paper
• Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative in vitro metabolism studies

  2021cites this paper
• Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450

  2021cites this paper